Bill

Bill > HR6710


US HR6710

US HR6710
To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.


summary

Introduced
02/11/2022
In Committee
02/14/2022
Crossed Over
Passed
Dead
01/03/2023

Introduced Session

117th Congress

Bill Summary

A BILL To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug prod- ucts, and devices, and for other purposes.

AI Summary

This bill directs the Secretary of Health and Human Services, through the Commissioner of Food and Drugs, to submit a report to Congress on barriers, including regulatory inefficiencies, to the domestic manufacturing of active pharmaceutical ingredients, finished drug products, and medical devices that are imported from outside the United States and critical to public health during a declared public health emergency. The report must identify the factors limiting such domestic manufacturing and recommend strategies to overcome the identified challenges. The Secretary may then implement the recommended strategies as appropriate.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (21)

Last Action

Referred to the Subcommittee on Health. (on 02/14/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...